We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Medtronic

Medtronic offers medical products and therapies for the treatment of cardiac and vascular diseases, diabetes, and neu... read more Featured Products: More products

Download Mobile App




Core Biopsy System Seeks Out Potential Lung Cancer

By HospiMedica International staff writers
Posted on 29 Jul 2015
A new minimally invasive endobronchial biopsy system can extract multiple lung core tissue samples with just a single pass.

The Medtronic GenCut Core Biopsy System allows pulmonologists and thoracic surgeons to collect multiple core samples from lesions deep inside the lungs. More...
Due to the proprietary blade design, the core biopsy system can shear and collect larger intact samples, providing pathology laboratories with tissue that enables combined cytology, histology, and molecular profiling. The system is intended for use via a flexible endoscope or in conjunction with the superDimension navigation system, which enables a minimally invasive approach to accessing difficult-to-reach areas of the lung.

The system consists of a core biopsy tool, an extension tube, a locking syringe, and a tissue removal brush. The core biopsy tool itself is comprised of a polymeric shaft with steel braid reinforcement and a stainless steel side-cutting tip; the extension tube connects to the proximal end of the core biopsy tool shaft to allow users to apply suction via the locking syringe. Once sampling is completed, the tissue removal brush can be inserted through the shaft to collect any remaining tissue not expelled through aspiration. The Medtronic GenCut Core Biopsy System and superDimension navigation system are products of Medtronic (Dublin, Ireland).

“Lung cancer diagnostic clinicians consistently state that tissue is the issue; when performing a biopsy, they need enough tissue for the pathologist to make a diagnosis and to ensure undamaged tissue for genetic testing and molecular analysis,” said Chuck Brynelsen, president of the early technologies business at the Medtronic minimally invasive therapies group. “As lung cancer drugs and therapies advance, the ability to provide earlier diagnosis and earlier, personalized treatment can potentially save lives.”

Lung cancer is a malignant tumor characterized by uncontrolled cell growth in tissues of the lung. If left untreated, this growth can spread beyond the lung by process of metastasis into nearby tissue or other parts of the body. Primary lung cancers are carcinomas that derive from epithelial cells, with the main types being small-cell lung carcinoma (SCLC) and non-small-cell lung carcinoma (NSCLC). The most common symptoms are coughing (including coughing up blood), weight loss, shortness of breath, and chest pains.

Related Links:

Medtronic



Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Open Stapler
PROXIMATE Linear Cutter
LED Surgical Lamp
ACEMST35/57
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.